Beta-arrestins: multifunctional cellular mediators - PubMed

Review

Beta-arrestins: multifunctional cellular mediators

Liza Barki-Harrington et al. Physiology (Bethesda). 2008 Feb.

Free article

Abstract

Initially thought to play a role only in G-protein-coupled receptor desensitization, beta-arrestins are ascribed with new roles such as scaffolding and signaling proteins by their own right. This review explores the many functions of beta-arrestins, with an emphasis on their recently identified role as regulators of receptor signaling.

Similar articles

• beta-arrestins: traffic cops of cell signaling.

  Lefkowitz RJ, Whalen EJ. Lefkowitz RJ, et al. Curr Opin Cell Biol. 2004 Apr;16(2):162-8. doi: 10.1016/j.ceb.2004.01.001. Curr Opin Cell Biol. 2004. PMID: 15196559 Review.

• Arrestin interactions with G protein-coupled receptors.

  Lohse MJ, Hoffmann C. Lohse MJ, et al. Handb Exp Pharmacol. 2014;219:15-56. doi: 10.1007/978-3-642-41199-1_2. Handb Exp Pharmacol. 2014. PMID: 24292823

• Phosphorylation barcoding as a mechanism of directing GPCR signaling.

  Liggett SB. Liggett SB. Sci Signal. 2011 Aug 9;4(185):pe36. doi: 10.1126/scisignal.2002331. Sci Signal. 2011. PMID: 21868354 Review.

• Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions.

  Golan M, Schreiber G, Avissar S. Golan M, et al. Curr Pharm Des. 2009;15(14):1699-708. doi: 10.2174/138161209788168038. Curr Pharm Des. 2009. PMID: 19442183 Review.

• Arrestins: role in the desensitization, sequestration, and vesicular trafficking of G protein-coupled receptors.

  Walther C, Ferguson SS. Walther C, et al. Prog Mol Biol Transl Sci. 2013;118:93-113. doi: 10.1016/B978-0-12-394440-5.00004-8. Prog Mol Biol Transl Sci. 2013. PMID: 23764051 Review.

Cited by

• Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.

  Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, Kovoor A, Gitelman SE, Rosenthal SM, von Zastrow M, Bouvier M. Rochdi MD, et al. Mol Pharmacol. 2010 May;77(5):836-45. doi: 10.1124/mol.109.061804. Epub 2010 Feb 16. Mol Pharmacol. 2010. PMID: 20159941 Free PMC article.

• β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Pathway in Alcoholic Liver Disease.

  Sun YY, Zhao YX, Li XF, Huang C, Meng XM, Li J. Sun YY, et al. Front Pharmacol. 2018 Sep 19;9:1031. doi: 10.3389/fphar.2018.01031. eCollection 2018. Front Pharmacol. 2018. PMID: 30283336 Free PMC article.

• Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.

  Monaco-Shawver L, Schwartz L, Tuluc F, Guo CJ, Lai JP, Gunnam SM, Kilpatrick LE, Banerjee PP, Douglas SD, Orange JS. Monaco-Shawver L, et al. J Leukoc Biol. 2011 Jan;89(1):113-25. doi: 10.1189/jlb.0410200. Epub 2010 Oct 12. J Leukoc Biol. 2011. PMID: 20940324 Free PMC article.

• Development of enhanced conformational sampling methods to probe the activation landscape of GPCRs.

  Abrol R, Serrano E, Santiago LJ. Abrol R, et al. Adv Protein Chem Struct Biol. 2022;128:325-359. doi: 10.1016/bs.apcsb.2021.11.001. Epub 2021 Dec 20. Adv Protein Chem Struct Biol. 2022. PMID: 35034722 Free PMC article. Review.

• Mechanisms of troponin release into serum in cardiac injury associated with COVID-19 patients.

  Solaro RJ, Rosas PC, Langa P, Warren CM, Wolska BM, Goldspink PH. Solaro RJ, et al. Int J Cardiol Cardiovasc Dis. 2021;1(2):41-47. doi: 10.46439/cardiology.1.006. Epub 2021 Mar 8. Int J Cardiol Cardiovasc Dis. 2021. PMID: 34734211 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon